Biochemistry of Schizophrenia and Addiction
Springer (Verlag)
978-94-009-8708-1 (ISBN)
Section 1: Pathogenesis.- 1 The role of a prostaglandin E1 deficiency in schizophrenia: interactions with dopamine and opiates.- 2 The pathogenesis of schizophrenia.- 3 Opiates, opioid peptides and their possible relevance to schizophrenia.- 4 The possible actions of peptides with opioid activity derived from pepsin hydrolysates of wheat gluten and other constituents of gluten in the function of the central nervous system.- 5 Preliminary studies of the identification of brain peptides in relation to the genesis and expression of schizophrenia.- 6 The role of the dopamine system in schizophrenia.- Section 2: Immunology.- 7 The relevance of immunopathology to research into schizophrenia.- 8 Some connections between immunoglobulins and schizophrenia.- 9 Antibodies to wheat proteins in schizophrenia: relationship or coincidence?.- 10 The effects of hormones on immune responses.- 11 Binding of chlorpromazine and HLA-A1 antibodies to human lymphocyte membranes.- 12 The possible role of a prostaglandin Ea deficiency in the immunological abnormalities seen in schizophrenia.- 13 Immunological reaction of psychotic patients to fractions of gluten.- Section 3: Addiction.- 14 ß-endorphin and endoloxone: messengers of the autonomic nervous system for the conservation or expenditure of bodily resources and energy in anticipation of famine or feast.- 15 The pharmacology of tobacco smoking in relation to schizophrenia.- 16 Alcoholism and schizophrenia: a basic science approach.- 17 Opiate dependence and tolerance: a pharmacological analysis.- Section 4: Puerperal Psychoses.- 18 Puerperal schizophrenia?.- Section 5: Enzymology.- 19 The digestion and absorption of dietary protein.- Section 6: Physiology.- 20 Correlation between behavioural responses and cardiovascular changes and thecentral nervous mechanisms responsible for them.- Section 7: Morbidity and Mortality.- 21 Schizophrenia and physical disease: a preliminary analysis of data from the Oxford Record Linkage Study.- Section 8: Drug Treatments.- 22 Depot neuroleptics and tardive dyskinesia: prospective study.- 23 Recent developments in the drug treatment of schizophrenia.
Zusatzinfo | 344 p. |
---|---|
Verlagsort | Dordrecht |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Geisteswissenschaften ► Psychologie ► Persönlichkeitsstörungen |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
ISBN-10 | 94-009-8708-0 / 9400987080 |
ISBN-13 | 978-94-009-8708-1 / 9789400987081 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich